Journal of Surgical Research
Volume 148, Issue 2 , Pages 164-171 , August 2008

The Role of Cytoprotective Cytokines in Cardiac Ischemia/Reperfusion Injury

  • Corey D. Anderson, M.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Sepideh Heydarkhan-Hagvall, Ph.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Katja Schenke-Layland, Ph.D.

      Affiliations

    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Jin Quan Yang, M.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Maria C. Jordan, M.D.

      Affiliations

    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Jeanne K. Kim, B.Sc.

      Affiliations

    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • David A. Brown, B.Sc.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Patricia A. Zuk, Ph.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Hillel Laks, M.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Kenneth P. Roos, Ph.D.

      Affiliations

    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • W. Robb MacLellan, M.D.

      Affiliations

    • The Cardiovascular Research Laboratories, Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Ramin E. Beygui, M.D.

      Affiliations

    • Department of Surgery, Cardiothoracic Surgery Division, David Geffen School of Medicine, University of California, Los Angeles, California
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095-1741.

Received 9 May 2007

References 

  1. Tang YL, Zhao Q, Qin X, et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg. 2005;80:229
  2. Berry MF, Engler EA, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006;290:H2196
  3. Nagaya N, Kangawa KK, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005;112:1128
  4. Toma C, Pittenger PM, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93
  5. Murry CE, Soonpaa SM, Reinecke MH, et al. Hematopoietic stem cells do not trans-differentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664
  6. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292
  7. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12:459
  8. Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for ACT-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661
  9. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11:367
  10. Wang Y, Ahmad N, Wani MA, et al. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via ACT pathway and angiogenesis. J Mol Cell Cardiol. 2004;37:1041
  11. Nakamura T, Nawa K, Ichihara A. A Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450
  12. Zarnegar R, Michalopoulos MG. The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol. 1995;29:1177
  13. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992;16:1227
  14. Kawaida K, Matsumoto K, Shimazu H, et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357
  15. Ohmichi H, Matsumoto K, Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: Pulmotrophic role in lung regeneration. Am J Physiol. 1996;270:L1031
  16. Rappolee DA, Iyer A, Patel Y. Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res. 1996;78:1028
  17. Matsumori A, Furukawa Y, Hashimoto T, et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun. 1996;221:391
  18. Ueda H, Sawa Y, Matsumoto K, et al. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg. 1999;67:1726
  19. Nakamura T, Mizumo S, Matsumoto K, et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest. 2000;106:1511
  20. Levesque JP, Hendy J, Takamatsu Y, et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111:187
  21. Tomita S, Mickle D, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002;123:1132
  22. Doitsidou M, Reichman-Fried M, Stebler J, et al. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell. 2002;111:647
  23. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322
  24. Abbott JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300
  25. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211
  26. Tanaka N, Dalton N, Mao L, et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109
  27. Li Y, Takemura G, Kosai K, et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation. 2003;107:2499
  28. Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005;97:663
  29. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001;108:407
  30. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10:494
  31. Rangappa S, Fen C, Lee EH, et al. T Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg. 2003;75:775
  32. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant. 2003;7:86
  33. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomized controlled trial. Lancet. 2006;367:113
  34. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222
  35. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med. 2006;355:1274

PII: S0022-4804(07)00492-1

doi: 10.1016/j.jss.2007.08.005

Journal of Surgical Research
Volume 148, Issue 2 , Pages 164-171 , August 2008

Article Tools

* Image Usage & Resolution